CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $185.7M, lower than 95% of all stocks globally
- PositionReturn on assets is 16.8%, higher than 95% of its Medical Instruments & Supplies peers (median 4%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.28%
Annual Rate
USD 0.04Paid quarterly
Payout Ratio
31.8%Sustainable
Paying Dividends
5 yr
Payback Period
6.8 yr
Last Ex-Dividend
May 28, 2026
Last Payment
Jun 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
185.70MUSDvs all stocks (USD)
Trailing P/E
1.63xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.04BUSDvs all stocks (USD)
Profit Margin
10.73%vs Medical Instruments & Supplies peers
Beta
0.8100xvs all stocks
52-Week Change
-67.96%vs all stocks
Forward Annual Dividend Yield
1.28%vs all stocks
Market Capitalization
185.70MUSDvs all stocks (USD)
Enterprise Value
1.37BUSDvs all stocks (USD)
Trailing P/E
1.63xvs Medical Instruments & Supplies peers
Forward P/E
1.78xvs Medical Instruments & Supplies peers
PEG Ratio
-0.0139xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
0.1758xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.31xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
4.13xvs Medical Instruments & Supplies peers
Gross Margin
57.62%vs Medical Instruments & Supplies peers
Profit Margin
10.73%vs Medical Instruments & Supplies peers
Operating Margin
19.34%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
16.84%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.04BUSDvs all stocks (USD)
Revenue per Share (TTM)
17.74USDUpdated Jul 9, 2026Quarterly Revenue Growth
-14.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
645.50MUSDvs all stocks (USD)
EBITDA (TTM)
331.50MUSDvs all stocks (USD)
Net Income (TTM)
111.90MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-14.36%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
213.50MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
195.80MUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.0400USDUpdated Jul 9, 2026Forward Annual Dividend Yield
1.28%vs all stocks
Trailing Annual Dividend Rate
0.4600USDUpdated Jul 9, 2026Trailing Annual Dividend Yield
14.70%vs all stocks
Payout Ratio
31.75%vs Medical Instruments & Supplies peers
Revenue
1.08BUSDFY2025 · Sep 30, 2025Cost of Goods Sold
403.60MUSDFY2025 · Sep 30, 2025Gross Profit
676.80MUSDFY2025 · Sep 30, 2025Operating Income
296.40MUSDvs all stocks (USD)
Pre-tax Income
136.30MUSDFY2025 · Sep 30, 2025Income Tax Expense
40.90MUSDFY2025 · Sep 30, 2025Net Income
95.40MUSDFY2025 · Sep 30, 2025EBIT
243.60MUSDFY2025 · Sep 30, 2025EBITDA (Income Statement)
338.60MUSDFY2025 · Sep 30, 2025Research & Development
37.30MUSDFY2025 · Sep 30, 2025Selling, General & Administrative
332.00MUSDFY2025 · Sep 30, 2025Other Operating Expenses
700.00KUSDFY2025 · Sep 30, 2025Non-operating Interest Expense
107.30MUSDFY2025 · Sep 30, 2025EPS (Basic)
1.64USDFY2025 · Sep 30, 2025EPS (Diluted)
1.62USDFY2025 · Sep 30, 2025Basic Shares Outstanding
58.17MSharesFY2025 · Sep 30, 2025Diluted Shares Outstanding
58.17MSharesFY2025 · Sep 30, 2025Net Income from Continuing Operations
95.40MUSDFY2025 · Sep 30, 2025Operating Cash Flow
200.70MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents (End of Period)
228.60MUSDFY2025 · Sep 30, 2025Income Tax Paid
50.10MUSDFY2025 · Sep 30, 2025Interest Paid
103.80MUSDFY2025 · Sep 30, 2025Starting Profit (CF Statement)
95.40MUSDFY2025 · Sep 30, 2025Depreciation & Amortization
40.70MUSDFY2025 · Sep 30, 2025Deferred Taxes (CF)
17.60MUSDFY2025 · Sep 30, 2025Stock-based Compensation
31.60MUSDFY2025 · Sep 30, 2025Other Non-cash Items
19.50MUSDFY2025 · Sep 30, 2025Change in Accounts Receivable (CF)
44.20MUSDFY2025 · Sep 30, 2025Change in Accounts Payable (CF)
-68.90MUSDFY2025 · Sep 30, 2025Change in Other Assets/Liabilities
20.60MUSDFY2025 · Sep 30, 2025Long-term Debt Payments
-186.00MUSDFY2025 · Sep 30, 2025Common Dividends Paid
-35.00MUSDFY2025 · Sep 30, 2025Other Financing Charges
-5.70MUSDFY2025 · Sep 30, 2025Net Financing Cash Flow
-226.70MUSDFY2025 · Sep 30, 2025Shares Outstanding
59.33MSharesUpdated Jul 9, 2026Float Shares
58.33MSharesUpdated Jul 9, 2026Shares Short
7.41MSharesUpdated Jul 9, 2026Short Ratio
2.03daysvs all stocks
Short % of Shares Outstanding
14.88%vs all stocks
% Held by Insiders
1.74%vs all stocks
% Held by Institutions
100.41%vs all stocks
Total Cash (MRQ)
184.90MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.12USDUpdated Jul 9, 2026Total Debt (MRQ)
1.37BUSDvs all stocks (USD)
Current Ratio (MRQ)
2.46xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
-10.55USDUpdated Jul 9, 2026Total Assets
1.09BUSDvs all stocks (USD)
Total Current Assets
631.40MUSDFY2025 · Sep 30, 2025Total Liabilities
1.74BUSDFY2025 · Sep 30, 2025Total Non-current Assets
459.50MUSDFY2025 · Sep 30, 2025Total Non-current Liabilities
1.48BUSDFY2025 · Sep 30, 2025Total Current Liabilities
261.50MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents
225.50MUSDFY2025 · Sep 30, 2025Accounts Receivable
145.60MUSDFY2025 · Sep 30, 2025Inventory
178.60MUSDFY2025 · Sep 30, 2025Accounts Payable
74.20MUSDFY2025 · Sep 30, 2025Short-term Debt
12.90MUSDFY2025 · Sep 30, 2025Long-term Debt
1.42BUSDFY2025 · Sep 30, 2025Other Non-current Liabilities
63.20MUSDFY2025 · Sep 30, 2025Common Stock (Book)
0.00USDFY2025 · Sep 30, 2025Retained Earnings
-445.60MUSDFY2025 · Sep 30, 2025Total Shareholders' Equity
-651.20MUSDvs all stocks (USD)
52-Week Low
2.77USDUpdated Jul 9, 202652-Week High
15.55USDUpdated Jul 9, 202652-Week Change
-67.96%vs all stocks
Beta
0.8100xvs all stocks
50-Day MA
5.54USDUpdated Jul 9, 2026200-Day MA
10.50USDUpdated Jul 9, 2026Avg 10-Day Volume
1.73MSharesUpdated Jul 9, 2026Avg 30-Day Volume
2.78MSharesUpdated Jul 9, 2026Diluted EPS (TTM)
1.89USDUpdated Jul 9, 2026Other Income / Expense
-52.80MUSDFY2025 · Sep 30, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on assets is 16.8%, higher than 95% of its Medical Instruments & Supplies peers (median 4%)Significant
Return on assets: 0.17Industry median: 0.04Industry P95: 0.13Peers compared: 65.00
P/E ratio is 1.63×, lower than 95% of its Medical Instruments & Supplies peers (median 30.34×)Notable
P/E ratio: 1.63Industry median: 30.34Industry P5: 14.42Peers compared: 65.00
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $185.7M, lower than 95% of all stocks globallySignificant
Market cap (USD): 185,695,629Global P5: 269,387,740.27
Revenue is $1.04B, above the global median of $520.53MNotable
Revenue (USD): 1,042,499,968Global Median: 520,528,949.311
Levered free cash flow is $195.8M, above the global median of $16.24MNotable
Levered free cash flow (USD): 195,800,000Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Boamax Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Advanced Innergy Holdings Limited
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Krsnaa Diagnostics Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Europen Endustri Insaat Sanayi ve Ticaret A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRule
HanJung Natural Connectivity System.co.,Ltd
Tier 1ProductionThroughput-Bound ConversionFlowRule
Turk Prysmian Kablo ve Sistemleri A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Asicland Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Angel Robotics Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shandong Longertek Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Arwana Citramulia Tbk.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Changhong Meiling Co., Ltd.
2 interpretationsPrice Below Mean With Profitability And Book ValueClose Below 40W SMA With Profitability
Zhejiang Taihua New Material Co., Ltd.
2 interpretationsPrice Below Mean With Profitability And Book ValueClose Below 40W SMA With Profitability
The Marzetti Company
2 interpretationsPrice Below Mean With Profitability And Book ValueClose Below 40W SMA With Profitability